AiDEA

Key Features

Some of the functionality we provide:

• Real time scoring
• Automated image and voice classification
• Sharable personalized reports
• Monitor cognitive decline overtime

Alzheimer’s disease (AD) is a progressive neurodegenerative disease where the patient can progress from preclinical AD to mild cognitive impairment (MCI), and subsequently mild, moderate, or severe dementia. Identification of patients with MCI helps early diagnosis of AD. However, multiple factors limit the early diagnosis of AD:

• Patients and caregivers rely on primary care physicians (PCPs) to initiate AD screening. PCPs hesitate to administer screening due to time limitations.
• Different cognitive test batteries are available, each with its strength and limitations. A single PCP may not be trained to administer every test.
• Early AD diagnosis requires measuring the cognitive decline over time, which implies repeated assessments and multiple doctor visits.

AiDEA overcomes the above limitations is to empower caregivers to administer the desired cognitive tests periodically and share results with PCPs